Status:
COMPLETED
An Evaluation of Treatment of Amblyopia in Children 7 To <18 Years Old
Lead Sponsor:
Jaeb Center for Health Research
Collaborating Sponsors:
National Eye Institute (NEI)
Conditions:
Amblyopia
Eligibility:
All Genders
7-17 years
Phase:
PHASE3
Brief Summary
The goals of this study are: * To determine the response rate of treatment of amblyopia in 7 to \<18 year olds. * To determine the frequency of recurrence of amblyopia in 7 to \<18 year olds after di...
Detailed Description
Most eye care practitioners believe that there is an age beyond which attempting to treat amblyopia is futile. It is generally held that the response to treatment is best when it is instituted at an e...
Eligibility Criteria
Inclusion
- Patients must be aged 7 to \<18 years and have amblyopia associated with strabismus, anisometropia, or both.
- Visual acuity in the amblyopic eye must be 20/40 to 20/400 inclusive and visual acuity in the sound eye must be 20/25 or better.
Exclusion
- Patients must not have received amblyopia treatment (other than spectacles) in the past month or more than one month of amblyopia treatment in the last 6 months.
Key Trial Info
Start Date :
October 1 2002
Trial Type :
INTERVENTIONAL
End Date :
December 1 2005
Estimated Enrollment :
507 Patients enrolled
Trial Details
Trial ID
NCT00094692
Start Date
October 1 2002
End Date
December 1 2005
Last Update
March 24 2010
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Wilmer Eye Institute
Baltimore, Maryland, United States, 21287-9028
2
Pennsylvania College of Optometry
Philadelphia, Pennsylvania, United States, 19141
3
Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15213